{"id":"azm-x-mg","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL5314922","moleculeType":"Small molecule","molecularWeight":"436.52"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Azithromycin works by binding to the 50S ribosomal subunit of bacteria, which prevents the formation of peptide bonds and ultimately inhibits protein synthesis. This leads to the death of the bacterial cell. Azithromycin is effective against a wide range of bacteria, including Gram-positive and Gram-negative bacteria.","oneSentence":"Azithromycin is a macrolide antibiotic that inhibits protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:03:18.853Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Chronic bronchitis"},{"name":"Acute exacerbations of chronic obstructive pulmonary disease (COPD)"}]},"trialDetails":[{"nctId":"NCT05385770","phase":"PHASE3","title":"Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects","status":"COMPLETED","sponsor":"Celltrion","startDate":"2022-07-08","conditions":"Essential Hypertension","enrollment":890}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"AZM X mg","genericName":"AZM X mg","companyName":"Celltrion","companyId":"celltrion","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AZM X mg is a small molecule used in a clinical study to treat Essential Hypertension. The study, conducted by Celltrion, compares the efficacy and safety of AZM X mg combined with different doses of AML (MG-S-2525) to AZM X' mg combined with AML Y mg.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}